- Categories :
- More
When Nothing Else Has Worked: What I Want You to Know About Spravato
By Dr. Anita Bangale, The Woodlands Wellness and Mind Spa
Before I opened my clinic, I spent nearly 20 years in hospitals as an emergency physician. Some of the patients I still think about most didn't come in with broken bones or chest pain. They came in because depression had pushed them to the edge. And so many said the same thing: "I've tried everything." Two medications. Three. Sometimes ten. They had done everything right, and they were still drowning.
That's why our clinic exists. We believe "treatment-resistant" should never mean "out of options," and that people who are hurting deserve care that is both cutting-edge...and genuinely kind.
You are not the problem
If antidepressants haven't worked for you, it isn't a character flaw. Researchers estimate that more than 30-40% of people with major depression don't get adequate relief from standard medications. Doctors call this treatment-resistant depression, and it's in our neighborhoods, our schools and our workplaces.
The six-week wait
Most antidepressants, like Zoloft, Lexapro, Prozac and Cymbalta, work on serotonin and norepinephrine, chemical messengers that carry signals between nerve cells. They keep more of those messengers hanging around where brain cells communicate.
Here's the puzzle: that chemical change happens within hours, but most people don't feel better for four to six weeks. Scientists now think the real benefit comes later, as the brain slowly rebuilds connections. When you're barely getting through each day, six weeks is an eternity. And if the medication doesn't work, the clock starts over.
A different key for a different lock
Spravato (esketamine) is an FDA-approved nasal spray made from one mirror-image half of the ketamine molecule. Instead of serotonin, it works on glutamate, the brain's most abundant "go" signal.
The science in more simple terms: esketamine blocks a glutamate receptor called NMDA. Counterintuitively, that sets off a brief burst of activity that releases BDNF, a protein often called "fertilizer" for brain cells. In laboratory studies, this regrows synapses, the tiny bridges between neurons, in the prefrontal cortex, the part of the brain that helps manage mood and decision-making. Chronic stress and depression shrink those bridges.
What the numbers say
Spravato was first approved in 2019. In January 2025, the FDA made it the first medication approved as a standalone treatment for treatment-resistant depression; in that trial, 22.5 percent of patients reached remission in four weeks versus 7.6 percent on placebo.
"Remission" means symptoms became minimal. For people who had already failed at least two medications, that's not a small win. That's getting your life back.
What a visit feels like
Spravato is only given in certified clinics, never sent home. With us, we help you administer the spray in a calm, private room, then relax for about two hours while we monitor your blood pressure and how you're feeling. Some people feel "floaty" or briefly detached; that usually fades before you leave. Plan on a ride home since you will not be able to drive after the session.
Treatment usually starts twice a week, then tapers to weekly or every other week. Many insurance plans cover it for patients who qualify. It isn't right for everyone, so we start with a thorough medical review.
Why we care
We call ourselves a "mind spa" on purpose. Healing from depression shouldn't feel cold or clinical. It should feel like someone finally sees you. I truly believe our job isn't just to give a medication; it's to listen, walk alongside you, until you feel like yourself again.
If you or someone you love has been stuck, let's talk. And if you're in crisis right now, call or text 988, any time.